| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD1 | 93 | 2021 | 485 | 18.690 |
Why?
|
| Antigen Presentation | 58 | 2021 | 1364 | 6.250 |
Why?
|
| Mycobacterium tuberculosis | 53 | 2022 | 1782 | 5.850 |
Why?
|
| Lipids | 50 | 2021 | 3131 | 5.330 |
Why?
|
| Glycolipids | 34 | 2021 | 215 | 4.850 |
Why?
|
| T-Lymphocytes | 70 | 2021 | 10329 | 4.590 |
Why?
|
| Mycobacterium | 19 | 2019 | 252 | 3.940 |
Why?
|
| Antigens, Bacterial | 28 | 2021 | 1170 | 3.270 |
Why?
|
| Receptors, Antigen, T-Cell | 25 | 2021 | 2410 | 3.230 |
Why?
|
| Oxazoles | 13 | 2017 | 214 | 2.830 |
Why?
|
| T-Lymphocyte Subsets | 22 | 2021 | 1914 | 2.830 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 16 | 2019 | 807 | 2.740 |
Why?
|
| Lymphocyte Activation | 43 | 2021 | 5989 | 2.240 |
Why?
|
| Mycolic Acids | 10 | 2020 | 57 | 2.030 |
Why?
|
| Membrane Lipids | 6 | 2021 | 254 | 1.820 |
Why?
|
| Natural Killer T-Cells | 12 | 2021 | 308 | 1.780 |
Why?
|
| Tuberculosis | 19 | 2021 | 1665 | 1.660 |
Why?
|
| Glycoproteins | 11 | 2021 | 2333 | 1.610 |
Why?
|
| Lipopeptides | 5 | 2017 | 88 | 1.590 |
Why?
|
| Antigens | 9 | 2018 | 1496 | 1.490 |
Why?
|
| Phospholipids | 9 | 2021 | 811 | 1.460 |
Why?
|
| Antigens, CD1d | 9 | 2021 | 233 | 1.400 |
Why?
|
| Mycobacterium Infections | 5 | 2016 | 120 | 1.170 |
Why?
|
| Bacterial Proteins | 17 | 2020 | 4155 | 1.070 |
Why?
|
| Autoantigens | 8 | 2021 | 914 | 1.050 |
Why?
|
| Histocompatibility Antigens Class I | 8 | 2019 | 1536 | 1.030 |
Why?
|
| Trehalose | 5 | 2021 | 94 | 0.930 |
Why?
|
| Endosomes | 10 | 2015 | 526 | 0.920 |
Why?
|
| Protein Conformation | 12 | 2019 | 4168 | 0.850 |
Why?
|
| T-Cell Antigen Receptor Specificity | 3 | 2017 | 92 | 0.850 |
Why?
|
| Galactosylceramides | 3 | 2017 | 97 | 0.840 |
Why?
|
| Skin | 8 | 2021 | 4456 | 0.830 |
Why?
|
| Lipid Metabolism | 14 | 2017 | 1995 | 0.790 |
Why?
|
| Antacids | 1 | 2019 | 104 | 0.780 |
Why?
|
| Autoimmunity | 4 | 2018 | 1309 | 0.770 |
Why?
|
| Antigen-Presenting Cells | 10 | 2021 | 970 | 0.750 |
Why?
|
| Tissue Donors | 3 | 2019 | 2035 | 0.730 |
Why?
|
| Dendritic Cells | 12 | 2015 | 2779 | 0.720 |
Why?
|
| Phagosomes | 1 | 2019 | 213 | 0.710 |
Why?
|
| Lipoproteins | 7 | 2016 | 907 | 0.700 |
Why?
|
| Diglycerides | 3 | 2019 | 180 | 0.690 |
Why?
|
| K562 Cells | 7 | 2021 | 662 | 0.650 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 1005 | 0.650 |
Why?
|
| Terpenes | 2 | 2015 | 112 | 0.640 |
Why?
|
| Cell Wall | 4 | 2017 | 449 | 0.640 |
Why?
|
| Models, Molecular | 14 | 2020 | 5778 | 0.640 |
Why?
|
| Lysosomes | 7 | 2019 | 927 | 0.620 |
Why?
|
| Siderophores | 3 | 2014 | 80 | 0.600 |
Why?
|
| Borrelia burgdorferi | 2 | 2019 | 170 | 0.570 |
Why?
|
| Nucleosides | 1 | 2015 | 132 | 0.570 |
Why?
|
| Molecular Structure | 7 | 2020 | 2072 | 0.560 |
Why?
|
| Virulence Factors | 2 | 2016 | 507 | 0.560 |
Why?
|
| Antitubercular Agents | 3 | 2020 | 1248 | 0.560 |
Why?
|
| Mass Spectrometry | 12 | 2020 | 2304 | 0.550 |
Why?
|
| Lectins, C-Type | 4 | 2021 | 617 | 0.550 |
Why?
|
| Rifampin | 1 | 2016 | 293 | 0.540 |
Why?
|
| Protein Multimerization | 5 | 2021 | 1046 | 0.530 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2014 | 89 | 0.530 |
Why?
|
| Arylsulfonates | 2 | 2021 | 10 | 0.530 |
Why?
|
| Protein Binding | 16 | 2020 | 9947 | 0.510 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2017 | 306 | 0.500 |
Why?
|
| Stereoisomerism | 9 | 2020 | 709 | 0.500 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 880 | 0.500 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4416 | 0.490 |
Why?
|
| Carbohydrates | 2 | 2007 | 320 | 0.490 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2016 | 1692 | 0.490 |
Why?
|
| Actinomycetales | 1 | 2012 | 47 | 0.480 |
Why?
|
| Benzofurans | 2 | 2021 | 156 | 0.480 |
Why?
|
| Cord Factors | 2 | 2020 | 7 | 0.480 |
Why?
|
| Cell Line | 23 | 2021 | 17137 | 0.460 |
Why?
|
| Iron | 4 | 2015 | 1669 | 0.450 |
Why?
|
| Mycobacterium kansasii | 2 | 2020 | 9 | 0.430 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 146 | 0.430 |
Why?
|
| Ceramides | 1 | 2011 | 174 | 0.420 |
Why?
|
| Lyme Disease | 2 | 2019 | 587 | 0.420 |
Why?
|
| Animals | 59 | 2020 | 170849 | 0.410 |
Why?
|
| Humans | 123 | 2022 | 686663 | 0.400 |
Why?
|
| Ligands | 10 | 2021 | 3189 | 0.390 |
Why?
|
| Models, Immunological | 5 | 2019 | 542 | 0.390 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 591 | 0.380 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2019 | 1649 | 0.370 |
Why?
|
| Molecular Sequence Data | 15 | 2014 | 19328 | 0.360 |
Why?
|
| Salmonella typhi | 2 | 2019 | 169 | 0.350 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 811 | 0.350 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2020 | 2729 | 0.320 |
Why?
|
| Structure-Activity Relationship | 7 | 2019 | 3313 | 0.310 |
Why?
|
| COP-Coated Vesicles | 2 | 2019 | 43 | 0.310 |
Why?
|
| Viruses | 1 | 2009 | 331 | 0.310 |
Why?
|
| Clone Cells | 5 | 2017 | 1776 | 0.310 |
Why?
|
| Bee Venoms | 2 | 2015 | 19 | 0.300 |
Why?
|
| Mice | 31 | 2020 | 80803 | 0.300 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2016 | 316 | 0.300 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 944 | 0.290 |
Why?
|
| Crystallography, X-Ray | 7 | 2021 | 2103 | 0.290 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2020 | 1200 | 0.290 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2005 | 97 | 0.280 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 986 | 0.280 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 14656 | 0.270 |
Why?
|
| Metabolomics | 1 | 2012 | 1299 | 0.270 |
Why?
|
| Virus Diseases | 1 | 2009 | 649 | 0.260 |
Why?
|
| Latent Tuberculosis | 2 | 2016 | 176 | 0.260 |
Why?
|
| Graves Disease | 1 | 2005 | 248 | 0.260 |
Why?
|
| Macrolides | 1 | 2004 | 222 | 0.260 |
Why?
|
| Monocytes | 4 | 2020 | 2643 | 0.250 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2011 | 339 | 0.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 4115 | 0.250 |
Why?
|
| Mycobacterium bovis | 3 | 2016 | 149 | 0.240 |
Why?
|
| Cross Reactions | 4 | 2019 | 912 | 0.240 |
Why?
|
| Polyisoprenyl Phosphate Sugars | 1 | 2001 | 2 | 0.240 |
Why?
|
| Embolism, Fat | 1 | 2002 | 56 | 0.240 |
Why?
|
| Databases, Factual | 3 | 2012 | 7865 | 0.230 |
Why?
|
| Membrane Transport Proteins | 2 | 2020 | 1036 | 0.230 |
Why?
|
| Membrane Proteins | 4 | 2020 | 8262 | 0.230 |
Why?
|
| Flow Cytometry | 8 | 2016 | 6230 | 0.230 |
Why?
|
| Tuberculosis Vaccines | 2 | 2019 | 44 | 0.230 |
Why?
|
| Recombinant Proteins | 8 | 2017 | 7060 | 0.220 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 364 | 0.220 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2020 | 34 | 0.210 |
Why?
|
| Balsams | 1 | 2020 | 9 | 0.210 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 37 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2018 | 24351 | 0.210 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1437 | 0.210 |
Why?
|
| Intracranial Embolism | 1 | 2002 | 212 | 0.210 |
Why?
|
| Cell Membrane | 6 | 2021 | 3982 | 0.210 |
Why?
|
| Immunophenotyping | 3 | 2020 | 1915 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 5114 | 0.200 |
Why?
|
| Base Sequence | 8 | 2014 | 13729 | 0.200 |
Why?
|
| Transfection | 5 | 2015 | 6329 | 0.200 |
Why?
|
| Antigens, Plant | 1 | 2020 | 85 | 0.200 |
Why?
|
| Models, Biological | 8 | 2014 | 10102 | 0.200 |
Why?
|
| Macrophages | 5 | 2020 | 5748 | 0.200 |
Why?
|
| Phosphatidic Acids | 1 | 2019 | 56 | 0.200 |
Why?
|
| Biological Transport | 5 | 2015 | 2191 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 4184 | 0.190 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 490 | 0.190 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2016 | 62 | 0.190 |
Why?
|
| Mycobacterium leprae | 2 | 2017 | 98 | 0.180 |
Why?
|
| Glycosylation | 5 | 2014 | 1162 | 0.180 |
Why?
|
| Endocytosis | 5 | 2014 | 1052 | 0.180 |
Why?
|
| Binding Sites | 3 | 2019 | 6499 | 0.180 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 446 | 0.180 |
Why?
|
| Bacteria | 1 | 2009 | 1998 | 0.180 |
Why?
|
| Hordeum | 1 | 2016 | 21 | 0.170 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 242 | 0.170 |
Why?
|
| Leprosy | 1 | 2017 | 130 | 0.170 |
Why?
|
| Conserved Sequence | 3 | 2019 | 1280 | 0.170 |
Why?
|
| Peptides | 3 | 2019 | 4537 | 0.170 |
Why?
|
| Sphingolipids | 1 | 2018 | 149 | 0.160 |
Why?
|
| Coat Protein Complex I | 2 | 2019 | 37 | 0.160 |
Why?
|
| Polyketide Synthases | 2 | 2017 | 42 | 0.160 |
Why?
|
| Interleukin-2 | 4 | 2015 | 1981 | 0.160 |
Why?
|
| Genome, Plant | 1 | 2016 | 93 | 0.160 |
Why?
|
| Wasp Venoms | 1 | 2015 | 20 | 0.160 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 1476 | 0.160 |
Why?
|
| Phosphatidylglycerols | 1 | 2015 | 46 | 0.160 |
Why?
|
| Chromatography, Liquid | 3 | 2020 | 958 | 0.150 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1403 | 0.150 |
Why?
|
| Killer Cells, Natural | 6 | 2012 | 2191 | 0.150 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 84 | 0.150 |
Why?
|
| Dermatitis | 1 | 2017 | 193 | 0.150 |
Why?
|
| Isomerism | 1 | 2015 | 221 | 0.150 |
Why?
|
| Fatty Acids | 4 | 2015 | 1701 | 0.150 |
Why?
|
| Histocompatibility Antigens | 2 | 2015 | 565 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2944 | 0.140 |
Why?
|
| Decidua | 1 | 2015 | 77 | 0.140 |
Why?
|
| Receptors, IgG | 2 | 2009 | 613 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 278 | 0.140 |
Why?
|
| Immunity | 2 | 2012 | 891 | 0.140 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 222 | 0.140 |
Why?
|
| Virulence | 3 | 2016 | 1309 | 0.140 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2015 | 141 | 0.140 |
Why?
|
| Hand Strength | 1 | 2017 | 424 | 0.140 |
Why?
|
| Lactones | 1 | 2017 | 349 | 0.140 |
Why?
|
| Acyltransferases | 3 | 2017 | 313 | 0.140 |
Why?
|
| Cell Separation | 4 | 2016 | 1874 | 0.140 |
Why?
|
| Allergens | 2 | 2020 | 1229 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2021 | 705 | 0.140 |
Why?
|
| Carbohydrate Conformation | 2 | 2007 | 209 | 0.140 |
Why?
|
| Chromatography, Thin Layer | 2 | 2012 | 246 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 5044 | 0.140 |
Why?
|
| Protein Isoforms | 5 | 2014 | 1746 | 0.140 |
Why?
|
| Immunotherapy, Active | 1 | 1994 | 77 | 0.140 |
Why?
|
| Milk | 1 | 2017 | 426 | 0.140 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2048 | 0.130 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 336 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 343 | 0.130 |
Why?
|
| Biological Assay | 1 | 2017 | 675 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3853 | 0.130 |
Why?
|
| Epitopes | 3 | 2015 | 2716 | 0.130 |
Why?
|
| AIDS-Related Complex | 1 | 1993 | 112 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 1872 | 0.130 |
Why?
|
| Models, Chemical | 2 | 2009 | 685 | 0.130 |
Why?
|
| Genome | 1 | 2021 | 1681 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 783 | 0.120 |
Why?
|
| Prevalence | 2 | 2020 | 14744 | 0.120 |
Why?
|
| Propaganda | 1 | 1992 | 5 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 327 | 0.120 |
Why?
|
| Saposins | 1 | 2012 | 16 | 0.120 |
Why?
|
| Interferon-gamma | 7 | 2021 | 3263 | 0.120 |
Why?
|
| Mental Healing | 1 | 1992 | 30 | 0.120 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 12680 | 0.120 |
Why?
|
| Books | 1 | 1992 | 24 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 785 | 0.120 |
Why?
|
| Psoriasis | 2 | 2017 | 939 | 0.120 |
Why?
|
| Cattle | 3 | 2013 | 4017 | 0.120 |
Why?
|
| Dimerization | 1 | 2014 | 948 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 273 | 0.120 |
Why?
|
| Protein Transport | 2 | 2013 | 2101 | 0.120 |
Why?
|
| Lectins | 1 | 2014 | 539 | 0.120 |
Why?
|
| Jurkat Cells | 3 | 2021 | 827 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2002 | 1336 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2009 | 377 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 564 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1516 | 0.110 |
Why?
|
| Guinea Pigs | 1 | 2013 | 1473 | 0.110 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2011 | 47 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 831 | 0.110 |
Why?
|
| Lysine | 2 | 2020 | 1036 | 0.110 |
Why?
|
| Software | 3 | 2021 | 4314 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2012 | 550 | 0.110 |
Why?
|
| Paratuberculosis | 1 | 2009 | 5 | 0.100 |
Why?
|
| Tuberculosis, Bovine | 1 | 2009 | 13 | 0.100 |
Why?
|
| Glycerophospholipids | 1 | 2009 | 33 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 478 | 0.100 |
Why?
|
| Hydroxy Acids | 1 | 2009 | 16 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3686 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 1041 | 0.100 |
Why?
|
| Langerhans Cells | 1 | 2010 | 194 | 0.100 |
Why?
|
| Lipopolysaccharides | 4 | 2013 | 2249 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 2039 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 4355 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2015 | 2115 | 0.100 |
Why?
|
| Methylation | 1 | 2012 | 1126 | 0.100 |
Why?
|
| Coculture Techniques | 4 | 2017 | 1393 | 0.100 |
Why?
|
| Antibody Specificity | 1 | 2011 | 1263 | 0.100 |
Why?
|
| Hepatitis B, Chronic | 1 | 2012 | 322 | 0.090 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 449 | 0.090 |
Why?
|
| Butyrates | 1 | 2009 | 168 | 0.090 |
Why?
|
| Escherichia coli | 4 | 2019 | 4411 | 0.090 |
Why?
|
| DNA Primers | 2 | 2012 | 3121 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 2935 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18495 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 4076 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2015 | 963 | 0.090 |
Why?
|
| Species Specificity | 1 | 2013 | 2683 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 1959 | 0.090 |
Why?
|
| Peru | 2 | 2021 | 850 | 0.090 |
Why?
|
| Amino Acids | 2 | 2014 | 1717 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 916 | 0.080 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2006 | 4 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 717 | 0.080 |
Why?
|
| Hydrogen Bonding | 2 | 2005 | 304 | 0.080 |
Why?
|
| CHO Cells | 2 | 2012 | 1458 | 0.080 |
Why?
|
| Biofilms | 1 | 2011 | 598 | 0.080 |
Why?
|
| Monosaccharides | 1 | 2006 | 67 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2002 | 6835 | 0.080 |
Why?
|
| Cells, Cultured | 8 | 2017 | 20620 | 0.080 |
Why?
|
| Mannose | 1 | 2006 | 116 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 15296 | 0.080 |
Why?
|
| Cricetinae | 2 | 2012 | 2624 | 0.080 |
Why?
|
| Galactans | 1 | 2005 | 31 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 2032 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2008 | 522 | 0.080 |
Why?
|
| Disease Progression | 2 | 2021 | 13204 | 0.080 |
Why?
|
| Cell-Free System | 1 | 2006 | 387 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 904 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 869 | 0.070 |
Why?
|
| Interleukins | 1 | 2010 | 832 | 0.070 |
Why?
|
| Sigma Factor | 1 | 2006 | 178 | 0.070 |
Why?
|
| Peptide Synthases | 1 | 2006 | 180 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21684 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6786 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2019 | 878 | 0.070 |
Why?
|
| Lung | 4 | 2020 | 9182 | 0.070 |
Why?
|
| Acylation | 2 | 2018 | 139 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2157 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 1626 | 0.070 |
Why?
|
| Hydroxylation | 1 | 2004 | 147 | 0.070 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 443 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1721 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 605 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2011 | 4441 | 0.070 |
Why?
|
| Adult | 14 | 2022 | 211400 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 247 | 0.070 |
Why?
|
| Peptidoglycan | 1 | 2005 | 256 | 0.060 |
Why?
|
| RNA | 1 | 2013 | 2493 | 0.060 |
Why?
|
| Hair | 1 | 2006 | 480 | 0.060 |
Why?
|
| BCG Vaccine | 2 | 2022 | 338 | 0.060 |
Why?
|
| Hybridomas | 1 | 2003 | 454 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2021 | 1026 | 0.060 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2002 | 58 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2006 | 1027 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1734 | 0.060 |
Why?
|
| Phylogeny | 2 | 2019 | 2863 | 0.060 |
Why?
|
| Phosphatidylethanolamines | 2 | 2017 | 134 | 0.060 |
Why?
|
| Capsaicin | 1 | 2003 | 250 | 0.060 |
Why?
|
| Blood Buffy Coat | 1 | 2021 | 7 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2297 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2011 | 9863 | 0.060 |
Why?
|
| Carbohydrate Sequence | 1 | 2001 | 427 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2019 | 1261 | 0.060 |
Why?
|
| Armadillos | 1 | 2000 | 8 | 0.060 |
Why?
|
| Self Tolerance | 1 | 2001 | 127 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2019 | 3395 | 0.050 |
Why?
|
| Dolichol Monophosphate Mannose | 1 | 2000 | 2 | 0.050 |
Why?
|
| Hepatocytes | 2 | 2012 | 1279 | 0.050 |
Why?
|
| Mycobacterium avium | 1 | 2000 | 30 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 331 | 0.050 |
Why?
|
| Lysophospholipids | 2 | 2015 | 347 | 0.050 |
Why?
|
| Female | 15 | 2021 | 375459 | 0.050 |
Why?
|
| Adenosine | 2 | 2016 | 805 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2000 | 95 | 0.050 |
Why?
|
| Male | 15 | 2021 | 352465 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 449 | 0.050 |
Why?
|
| Gene Expression | 4 | 2019 | 8182 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3557 | 0.050 |
Why?
|
| Skin Care | 1 | 2020 | 57 | 0.050 |
Why?
|
| Patch Tests | 1 | 2020 | 82 | 0.050 |
Why?
|
| Liposomes | 2 | 2014 | 757 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 1403 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 49 | 0.050 |
Why?
|
| Cosmetics | 1 | 2020 | 88 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2006 | 976 | 0.050 |
Why?
|
| Esters | 1 | 2020 | 221 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4913 | 0.050 |
Why?
|
| Cytokines | 4 | 2016 | 7147 | 0.050 |
Why?
|
| Diet | 1 | 2017 | 7351 | 0.050 |
Why?
|
| South Africa | 2 | 2015 | 1496 | 0.050 |
Why?
|
| Bronchi | 1 | 2003 | 873 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2020 | 212 | 0.050 |
Why?
|
| Culture Media | 1 | 2020 | 968 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23739 | 0.040 |
Why?
|
| Mycobacterium marinum | 1 | 2017 | 20 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 216468 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 152 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2005 | 1175 | 0.040 |
Why?
|
| HIV Infections | 2 | 2015 | 14979 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2214 | 0.040 |
Why?
|
| Mycobacterium phlei | 1 | 2016 | 3 | 0.040 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2020 | 146 | 0.040 |
Why?
|
| Rhodococcus equi | 1 | 2016 | 18 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2016 | 54 | 0.040 |
Why?
|
| Kinetics | 2 | 2020 | 6979 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 386 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 239 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 2011 | 385 | 0.040 |
Why?
|
| Haploidy | 1 | 2016 | 151 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 515 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4256 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9661 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 1124 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2016 | 142 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2020 | 452 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4297 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 2922 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6450 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 438 | 0.040 |
Why?
|
| Larva | 1 | 2017 | 515 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2016 | 253 | 0.040 |
Why?
|
| Diterpenes | 1 | 2016 | 183 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 651 | 0.040 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 72 | 0.040 |
Why?
|
| Protein Footprinting | 1 | 2014 | 10 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2017 | 337 | 0.040 |
Why?
|
| Toxoplasma | 1 | 1996 | 155 | 0.040 |
Why?
|
| Phosphatidylinositols | 2 | 2010 | 283 | 0.040 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 210 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2016 | 624 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 290 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 1858 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 17251 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 423 | 0.030 |
Why?
|
| Salts | 1 | 2014 | 64 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2015 | 516 | 0.030 |
Why?
|
| Genome, Bacterial | 2 | 2009 | 800 | 0.030 |
Why?
|
| Computational Biology | 2 | 2021 | 3612 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 1210 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1993 | 219 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2017 | 626 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 449 | 0.030 |
Why?
|
| Leukapheresis | 1 | 1993 | 128 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 69278 | 0.030 |
Why?
|
| Sputum | 1 | 2015 | 464 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6711 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2012 | 33 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 215 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1994 | 2307 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1358 | 0.030 |
Why?
|
| History, 15th Century | 1 | 1992 | 34 | 0.030 |
Why?
|
| History, 16th Century | 1 | 1992 | 81 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2012 | 236 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 994 | 0.030 |
Why?
|
| Printing | 1 | 1992 | 57 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 2009 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 267 | 0.030 |
Why?
|
| Neuroglia | 1 | 2017 | 937 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1994 | 10439 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 572 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1577 | 0.030 |
Why?
|
| Acute Disease | 1 | 2002 | 7202 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 1281 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 294 | 0.030 |
Why?
|
| Mutation | 5 | 2019 | 28848 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2173 | 0.030 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 461 | 0.030 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 213 | 0.030 |
Why?
|
| Mycobacterium avium subsp. paratuberculosis | 1 | 2009 | 4 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2010 | 119 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 13073 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2016 | 2600 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 2487 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2009 | 57 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 936 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2016 | 568 | 0.030 |
Why?
|
| Inflammation | 1 | 2009 | 9617 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 412 | 0.020 |
Why?
|
| Germany | 1 | 1992 | 852 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2775 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2014 | 1152 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1994 | 2296 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 337 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 801 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2575 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1710 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 1953 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1700 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 215 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1659 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2054 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 6150 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 61 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 33918 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2014 | 1717 | 0.020 |
Why?
|
| Glucose | 1 | 2020 | 4016 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 4952 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 1165 | 0.020 |
Why?
|